Eczema Beyond the Skin: A 2026 Review of Allergic and Nonallergic Comorbidities

November 9, 2026

AI-generated illustration: Dr. Arsy Hydration Barrier Repair Jar(1)

Evidence summary for education only; not individualized medical advice.

What “comorbidity” means

A 2026 review summarizes conditions reported more often alongside atopic dermatitis, including asthma, allergic rhinitis, food allergy, sleep disturbance and selected mental-health or metabolic outcomes. Co-occurrence can reflect shared biology, treatment effects, healthcare use or confounding. It does not establish that eczema caused another disease.

Why severity and age matter

Risk estimates vary by age, disease activity, diagnostic method and study design. A child with mild intermittent eczema should not be assumed to have the same profile as an adult with longstanding severe disease. Absolute risk matters more than a relative increase viewed alone.

Useful clinical questions

Screening should be symptom-led: nighttime waking, wheeze, nasal symptoms, immediate food reactions, anxiety, depressed mood and functional impairment. Broad laboratory panels can create false alarms when there is no specific clinical question.

What the evidence cannot prove

Much of the literature is observational. Reverse causation and detection bias remain possible, and associations may shrink after adjustment. The review supports awareness and coordinated care, not automatic testing of every patient.

Safety

Infants with poor feeding, breathing difficulty, widespread hives or lethargy need urgent assessment. Families should not remove major foods solely because eczema is present.

Bottom line

Eczema care is strongest when clinicians ask about the whole person while reserving tests and referrals for findings that could change care.

Related Dr. Arsy research

References

← Back to Doctor's Notes